Business Context and Reporting Period
Company: Acadia Healthcare Company, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 21, 2016
Event: Entry into a Material Definitive Agreement regarding debt repricing.
Key Financial Metrics
This filing focuses on debt restructuring rather than operational performance metrics. Specific data points include:
- Outstanding Debt: $950.2 million (Tranche B-2 Term Loan as of July 31, 2016).
- Interest Rate Reduction (Eurodollar Rate Loans): Reduced from 3.75% to 3.00%.
- Interest Rate Reduction (Base Rate Loans): Reduced from 2.75% to 2.00%.
- Revenue, Profit, Cash Flow, Margins: The filing text does not provide a clear value for these operational metrics.
Material Changes Versus Prior Period
The primary material change is the execution of the Tranche B-2 Repricing Amendment to the Amended and Restated Credit Agreement (dated December 31, 2012). This amendment lowers the Applicable Rate on the outstanding term loan, resulting in reduced interest expense compared to the prior terms.
Guidance, Outlook, and Risks
Management Commentary: The Company continues to explore additional amendments and repricings of its credit agreement to benefit from current senior secured debt market terms.
Outlook: There is no assurance that additional amendments or repricings will be completed on terms satisfactory to the Company.
Risks: The filing includes standard forward-looking statement disclaimers, noting that actual results could differ materially from expectations due to risks and uncertainties outside the Company's control.
Investor Verification Checklist
- Verify the full text of the Tranche B-2 Repricing Amendment (Exhibit 10) for covenants or conditions not summarized in the 8-K.
- Confirm the total outstanding debt balance as of the most recent quarter to assess the total impact of the rate reduction.
- Monitor future filings for updates on the exploration of additional debt amendments mentioned in Item 7.01.
- Review the Company's most recent 10-Q or 10-K for comprehensive revenue, profit, and liquidity data not included in this current report.